Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care.
Koss CA, Gandhi M, Halvas EK, Okochi H, Chu C, Glidden DV, Georgetti Gomez L, Heaps AL, Conroy AA, Tran M, Shetler C, Hoeth D, Kuncze K, Louie A, Rivera Garza H, Wafula Mugoma E, Penrose KJ, Chohan BH, Ayieko JO, Mills A, Patel RR, Mellors JW, Parikh UM. Koss CA, et al. Among authors: mellors jw. Open Forum Infect Dis. 2024 Aug 26;11(9):ofae468. doi: 10.1093/ofid/ofae468. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39229286 Free PMC article.
Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis.
Landovitz RJ, Delany-Moretlwe S, Fogel JM, Marzinke MA, Piwowar-Manning E, Richardson P, Halvas EK, Mellors JW, Persaud D, Kofron R, McCauley M, Rose S, Rinehart AR, Rooney JF, Adeyeye A, Cohen MS, Donnell D, Hosseinipour MC, Grinsztejn B, Eshleman SH; HPTN 083 and 084 Study Teams. Landovitz RJ, et al. Among authors: mellors jw. N Engl J Med. 2024 Oct 3;391(13):1253-1256. doi: 10.1056/NEJMc2402088. Epub 2024 Jul 24. N Engl J Med. 2024. PMID: 39046350 Free PMC article. No abstract available.
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment.
Parikh UM, Heaps AL, Moisi D, Gordon KC, Mellors JW, Choudhary MC, Deo R, Moser C, Klekotka P, Landay AL, Currier JS, Eron JJ, Chew KW, Smith DM, Li JZ, Sieg SF; Team ACTIV-2/A5401 Study. Parikh UM, et al. Among authors: mellors jw. Pathog Immun. 2024 Aug 15;9(2):58-78. doi: 10.20411/pai.v9i2.715. eCollection 2024. Pathog Immun. 2024. PMID: 39165724 Free PMC article.
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response.
Paul MK, Choudhary MC, Heaps AL, Deo R, Moisi D, Gordon KC, Mellors JW, Moser C, Klekotka P, Landay A, Currier JS, Eron JJ, Chew KW, Smith DM, Sieg SF, Parikh UM, Li JZ; ACTIV-2/A5401 Study Team. Paul MK, et al. Among authors: mellors jw. Pathog Immun. 2024 Aug 21;9(2):79-93. doi: 10.20411/pai.v9i2.718. eCollection 2024. Pathog Immun. 2024. PMID: 39247686 Free PMC article.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Shah NS, Kityo C, Hughes MD, McCarthy C, Wallis C, Hosseinipour M, Langat D, Nyirenda M, Rassool M, Dawson R, Joseph Y, Some F, Mngqbisa R, Mukwekwerere PG, Woolley E, Godfrey C, Manabe YC, Mellors JW, Flexner C, Maartens G; ACTG A5381/Hakim Study Team. Shah NS, et al. Among authors: mellors jw. Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093/cid/ciae269. Online ahead of print. Clin Infect Dis. 2024. PMID: 38739755
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
Crowell TA, Ritz J, Zheng L, Naqvi A, Cyktor JC, Puleo J, Clagett B, Lama JR, Kanyama C, Little SJ, Cohn SE, Riddler SA, Collier AC, Heath SL, Tantivitayakul P, Grinsztejn B, Arduino RC, Rooney JF, van Zyl GU, Coombs RW, Fox L, Ananworanich J, Eron JJ, Sieg SF, Mellors JW, Daar ES; AIDS Clinical Trials Group (ACTG) A5354/EARLIER Study Team. Crowell TA, et al. Among authors: mellors jw. AIDS. 2024 Jul 1;38(8):1141-1152. doi: 10.1097/QAD.0000000000003881. Epub 2024 Mar 13. AIDS. 2024. PMID: 38489580 Clinical Trial.
Single-cell analyses reveal that monocyte gene expression profiles influence HIV-1 reservoir size in acutely treated cohorts.
Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum L, Waickman A, Shangguan S, Paquin-Proulx D, Creegan M, Bose M, Machmach K, McGraw A, Narahari A, Currier JR, Sacdalan C, Phanuphak N, Apps R, Corley M, Ndhlovu LC, Slike B, Krebs SJ, Anonworanich J, Tovanabutra S, Robb ML, Eller MA, Laird GM, Cyktor J, Daar ES, Crowell TA, Mellors JW, Vasan S, Michael NL, Kirchhoff F, Thomas R. Ehrenberg PK, et al. Among authors: mellors jw. bioRxiv [Preprint]. 2024 Nov 15:2024.11.12.623270. doi: 10.1101/2024.11.12.623270. bioRxiv. 2024. PMID: 39605411 Free PMC article. Preprint.
Brief Report: Low-Dose Methotrexate Does Not Affect Measures of HIV-1 Persistence in Individuals With Chronically Treated HIV-1 Infection.
Cyktor JC, Yeh E, Ribaudo H, Hoeth D, Naqvi A, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Tawakol A, Lederman MM, Stein JH, Deeks SG, Currier JS, Hsue PY, Mellors JW; A5314 Team. Cyktor JC, et al. Among authors: mellors jw. J Acquir Immune Defic Syndr. 2024 Aug 15;96(5):481-485. doi: 10.1097/QAI.0000000000003453. J Acquir Immune Defic Syndr. 2024. PMID: 39287554 Clinical Trial.
427 results